FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904057341> ?p ?o ?g. }

• W2904057341 endingPage "S216" @default.
• W2904057341 startingPage "S206" @default.
• W2904057341 abstract "Abstract Background We conducted a national antimicrobial surveillance study of both gram-positive and gram-negative organisms isolated from hospitalized patients. This report presents data on antimicrobial susceptibility among 4998 organisms collected in China between 2012 and 2014. Method The minimum inhibitory concentrations (MICs) and susceptibilities of ceftaroline/avibactam (CPA), ceftazidime/avibactam (CZA) and a range of comparative agents were determined according to guidelines established by the Clinical and Laboratory Standards Institute (CLSI). Results The highest overall susceptibility levels for all Enterobacteriaceae during the study period were observed for CPA, CZA, doripenem (DOR), meropenem (MEM), and amikacin (AMK), which were all &gt;90%. However, both CPT and CAZ alone and in combination with avibactam showed low activities for Acinetobacter spp., whereas CPA and CZA exhibited MIC90 values for Pseudomonas aeruginosa that were reduced by 4- and 8-fold, respectively, compared with those of CPT and CAZ. High susceptibilities of Acinetobacter spp. and P. aeruginosa to colistin and P. aeruginosa to AMK were observed. For the gram-positive strains, no significant activity changes were seen for Enterococcus, Staphylococcus, and viridans group streptococci to CPT or CAZ alone or in combination with avibactam, whereas Streptococcus pneumoniae and β-hemolytic Streptococcus showed almost 100% susceptibility to both CPT and CPA. Conclusion The addition of 4 mg/L avibactam greatly increased the activities of CPT and CAZ against most Enterobacteriaceae and P. aeruginosa isolates, whereas no significant changes were observed in Acinetobacter spp. or any of the gram-positive strains." @default.
• W2904057341 created "2018-12-22" @default.
• W2904057341 creator A5002643577 @default.
• W2904057341 creator A5008949726 @default.
• W2904057341 creator A5010846884 @default.
• W2904057341 creator A5021023077 @default.
• W2904057341 creator A5026565474 @default.
• W2904057341 creator A5032383307 @default.
• W2904057341 creator A5033223088 @default.
• W2904057341 creator A5035671110 @default.
• W2904057341 creator A5038074690 @default.
• W2904057341 creator A5038605675 @default.
• W2904057341 creator A5058985073 @default.
• W2904057341 creator A5077812673 @default.
• W2904057341 creator A5078581178 @default.
• W2904057341 creator A5083895780 @default.
• W2904057341 creator A5086015188 @default.
• W2904057341 creator A5086957200 @default.
• W2904057341 date "2018-11-13" @default.
• W2904057341 modified "2023-10-15" @default.
• W2904057341 title "In Vitro Activities of Ceftaroline/Avibactam, Ceftazidime/Avibactam, and Other Comparators Against Pathogens From Various Complicated Infections in China" @default.
• W2904057341 cites W2018229558 @default.
• W2904057341 cites W2026372260 @default.
• W2904057341 cites W2045211463 @default.
• W2904057341 cites W2056317617 @default.
• W2904057341 cites W2062362165 @default.
• W2904057341 cites W2068735589 @default.
• W2904057341 cites W2074875549 @default.
• W2904057341 cites W2095640955 @default.
• W2904057341 cites W2099303284 @default.
• W2904057341 cites W2100232903 @default.
• W2904057341 cites W2107242109 @default.
• W2904057341 cites W2128484737 @default.
• W2904057341 cites W2133786572 @default.
• W2904057341 cites W2157019531 @default.
• W2904057341 cites W2161532342 @default.
• W2904057341 cites W2163292670 @default.
• W2904057341 cites W2171447404 @default.
• W2904057341 cites W2220188301 @default.
• W2904057341 cites W2777656085 @default.
• W2904057341 doi "https://doi.org/10.1093/cid/ciy659" @default.
• W2904057341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30423043" @default.
• W2904057341 hasPublicationYear "2018" @default.
• W2904057341 type Work @default.
• W2904057341 sameAs 2904057341 @default.
• W2904057341 citedByCount "13" @default.
• W2904057341 countsByYear W29040573412019 @default.
• W2904057341 countsByYear W29040573412020 @default.
• W2904057341 countsByYear W29040573412021 @default.
• W2904057341 countsByYear W29040573412022 @default.
• W2904057341 crossrefType "journal-article" @default.
• W2904057341 hasAuthorship W2904057341A5002643577 @default.
• W2904057341 hasAuthorship W2904057341A5008949726 @default.
• W2904057341 hasAuthorship W2904057341A5010846884 @default.
• W2904057341 hasAuthorship W2904057341A5021023077 @default.
• W2904057341 hasAuthorship W2904057341A5026565474 @default.
• W2904057341 hasAuthorship W2904057341A5032383307 @default.
• W2904057341 hasAuthorship W2904057341A5033223088 @default.
• W2904057341 hasAuthorship W2904057341A5035671110 @default.
• W2904057341 hasAuthorship W2904057341A5038074690 @default.
• W2904057341 hasAuthorship W2904057341A5038605675 @default.
• W2904057341 hasAuthorship W2904057341A5058985073 @default.
• W2904057341 hasAuthorship W2904057341A5077812673 @default.
• W2904057341 hasAuthorship W2904057341A5078581178 @default.
• W2904057341 hasAuthorship W2904057341A5083895780 @default.
• W2904057341 hasAuthorship W2904057341A5086015188 @default.
• W2904057341 hasAuthorship W2904057341A5086957200 @default.
• W2904057341 hasConcept C2775933652 @default.
• W2904057341 hasConcept C2776968632 @default.
• W2904057341 hasConcept C2777406300 @default.
• W2904057341 hasConcept C2777637488 @default.
• W2904057341 hasConcept C2778523567 @default.
• W2904057341 hasConcept C2779259085 @default.
• W2904057341 hasConcept C4937899 @default.
• W2904057341 hasConcept C501593827 @default.
• W2904057341 hasConcept C523546767 @default.
• W2904057341 hasConcept C54355233 @default.
• W2904057341 hasConcept C71924100 @default.
• W2904057341 hasConcept C86803240 @default.
• W2904057341 hasConcept C89423630 @default.
• W2904057341 hasConceptScore W2904057341C2775933652 @default.
• W2904057341 hasConceptScore W2904057341C2776968632 @default.
• W2904057341 hasConceptScore W2904057341C2777406300 @default.
• W2904057341 hasConceptScore W2904057341C2777637488 @default.
• W2904057341 hasConceptScore W2904057341C2778523567 @default.
• W2904057341 hasConceptScore W2904057341C2779259085 @default.
• W2904057341 hasConceptScore W2904057341C4937899 @default.
• W2904057341 hasConceptScore W2904057341C501593827 @default.
• W2904057341 hasConceptScore W2904057341C523546767 @default.
• W2904057341 hasConceptScore W2904057341C54355233 @default.
• W2904057341 hasConceptScore W2904057341C71924100 @default.
• W2904057341 hasConceptScore W2904057341C86803240 @default.
• W2904057341 hasConceptScore W2904057341C89423630 @default.
• W2904057341 hasFunder F4320323137 @default.
• W2904057341 hasFunder F4320326853 @default.
• W2904057341 hasFunder F4320335777 @default.
• W2904057341 hasIssue "suppl_2" @default.
• W2904057341 hasLocation W29040573411 @default.

• next